Loading...
Loading...
A report from Wedbush reiterates its Outperform rating and lowers its price target from $30 to $25 on Molina Healthcare
MOH.
The report states, “Our price target reflects the growth opportunity from Medicaid expansion ($40B pipeline). Risks to the attainment of our price target include high exposure to government businesses and the company's position as a price taker."
MOH closed yesterday at $18.32.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in